Novo Nordisk A/S - share repurchase programme
18 déc. 2023 08h37 HE
|
Novo Nordisk A/S
Bagsværd, Denmark, 18 December 2023 – On 6 November 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...
Novo Nordisk A/S - share repurchase programme
11 déc. 2023 08h27 HE
|
Novo Nordisk A/S
Bagsværd, Denmark, 11 December 2023 – On 6 November 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...
Novo Nordisk A/S - share repurchase programme
04 déc. 2023 07h42 HE
|
Novo Nordisk A/S
Bagsværd, Denmark, 04 December 2023 – On 6 November 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...
Novo Nordisk A/S - share repurchase programme
27 nov. 2023 09h00 HE
|
Novo Nordisk A/S
Bagsværd, Denmark, 27 November 2023 – On 6 November 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...
Novo Nordisk invests more than 16 billion Danish kroner in expansion of production facilities in Chartres, France
23 nov. 2023 11h02 HE
|
Novo Nordisk A/S
Bagsværd, Denmark, 23 November 2023 – Novo Nordisk today announced the investment of more than 16 billion Danish kroner (2.1 billion euros) starting in 20231 to expand the existing production site in...
Novo Nordisk A/S - share repurchase programme
20 nov. 2023 10h03 HE
|
Novo Nordisk A/S
Bagsværd, Denmark, 20 November 2023 – On 6 November 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
14 nov. 2023 06h07 HE
|
Novo Nordisk A/S
Bagsværd, Denmark, 14 November 2023 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated...
Novo Nordisk A/S - share repurchase programme
13 nov. 2023 14h30 HE
|
Novo Nordisk A/S
Bagsværd, Denmark, 13 November 2023 – On 6 November 2023, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...
Trading in Novo Nordisk shares by board members, executives and associated persons
13 nov. 2023 07h04 HE
|
Novo Nordisk A/S
Bagsværd, Denmark, 13 November 2023 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated...
Novo Nordisk A/S: Semaglutide 2.4 mg (Wegovy®) cardiovascular outcomes data presented at American Heart Association Scientific Sessions and simultaneously published in New England Journal of Medicine
11 nov. 2023 08h31 HE
|
Novo Nordisk A/S
Semaglutide 2.4 mg delivered a statistically significant 20% risk reduction in major adverse cardiovascular events (MACE) with risk reductions demonstrated consistently across age, gender, ethnicity...